LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 2543 | 3573 | 5578 | 0.6405 | 0.3392 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP5 | 1 | O02 | 72 | hr | 2543 | 1711 | 5578 | 0.3067 | -0.2743 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP5 | 2 | O02 | 72 | hr | 2543 | 1358 | 5578 | 0.2434 | -0.3906 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP5 | 3 | O02 | 72 | hr | 2543 | 1659 | 5578 | 0.2974 | -0.2914 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 1 | O02 | 72 | hr | 2543 | 1673 | 5578 | 0.2999 | -0.2868 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 2 | O02 | 72 | hr | 2543 | 1758 | 5578 | 0.3151 | -0.2588 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 3 | O02 | 72 | hr | 2543 | 1736 | 5578 | 0.3112 | -0.2660 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 2543 | 1298 | 5578 | 0.2327 | -0.4103 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 2543 | 977 | 5578 | 0.1751 | -0.5161 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 2543 | 1227 | 5578 | 0.2200 | -0.4337 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 2543 | 1296 | 5578 | 0.2323 | -0.4110 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 2543 | 1618 | 5578 | 0.2900 | -0.3049 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 2543 | 1473 | 5578 | 0.2640 | -0.3527 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 2543 | 5623 | 5578 | 1.0079 | 1.0146 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 2543 | 5456 | 5578 | 0.9780 | 0.9596 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 2543 | 5706 | 5578 | 1.0228 | 1.0420 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 2543 | 1065 | 5578 | 0.1909 | -0.4871 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 2543 | 1016 | 5578 | 0.1821 | -0.5033 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 2543 | 1027 | 5578 | 0.1841 | -0.4996 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 1 | F20 | 72 | hr | 2543 | 4396 | 5578 | 0.7880 | 0.6104 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 2 | F20 | 72 | hr | 2543 | 4303 | 5578 | 0.7713 | 0.5797 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 3 | F20 | 72 | hr | 2543 | 4409 | 5578 | 0.7903 | 0.6146 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 1 | B14 | 72 | hr | 2543 | 1369 | 5578 | 0.2454 | -0.3869 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 2 | B14 | 72 | hr | 2543 | 1518 | 5578 | 0.2721 | -0.3379 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 3 | B14 | 72 | hr | 2543 | 1413 | 5578 | 0.2533 | -0.3725 |